Applying artificial intelligence for cancer immunotherapy
Artificial intelligence (AI) is a general term that refers to the use of a machine to imitate intelligent behavior for performing complex tasks with minimal human intervention, such as machine learning; this technology is revolutionizing and reshaping medicine. AI has considerable potential to perfe...
Saved in:
Main Authors: | Zhijie Xu (Author), Xiang Wang (Author), Shuangshuang Zeng (Author), Xinxin Ren (Author), Yuanliang Yan (Author), Zhicheng Gong (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum: SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via the Akt/GSK3β/β-Catenin Signaling Axis
by: Shuang Dai, et al.
Published: (2019) -
SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-Catenin Signaling Axis
by: Shuang Dai, et al.
Published: (2018) -
The antibiotic drug tigecycline: A focus on its promising anticancer properties
by: Zhijie Xu, et al.
Published: (2016) -
Applied Computing and Artificial Intelligence
Published: (2023) -
Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer
by: Yuan Cai, et al.
Published: (2021)